blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1697521

EP1697521 - MULTI PLASMID SYSTEM FOR THE PRODUCTION OF INFLUENZA VIRUS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  08.04.2011
Database last updated on 28.06.2024
Most recent event   Tooltip17.11.2017Lapse of the patent in a contracting statepublished on 20.12.2017  [2017/51]
Applicant(s)For all designated states
MedImmune, LLC
Corporation Trust Center 1209 Orange Street
Wilmington DE 19801 / US
[2010/15]
Former [2006/36]For all designated states
MedImmune Vaccines, Inc.
One Medimmune Way
Gaithersburg, MD 20878 / US
Inventor(s)01 / DUKE, Greg
715 Upland Road
Redwood City, California 94062 / US
02 / KEMBLE, George
Via Grande Drive
Saratoga, CA 95070 / US
 [2006/36]
Representative(s)Chapman, Paul Gilmour, et al
Marks & Clerk LLP The Beacon
176 St Vincent Street
Glasgow G2 5SG / GB
[N/P]
Former [2008/33]Chapman, Paul Gilmour, et al
Marks & Clerk 19 Royal Exchange Square Glasgow
G1 3AE / GB
Former [2006/36]Chapman, Paul Gilmour, et al
Marks & Clerk 19 Royal Exchange Square
Glasgow G1 3AE / GB
Application number, filing date04814807.622.12.2004
[2006/36]
WO2004US42669
Priority number, dateUS20030532164P23.12.2003         Original published format: US 532164 P
[2006/36]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2005062820
Date:14.07.2005
Language:EN
[2005/28]
Type: A2 Application without search report 
No.:EP1697521
Date:06.09.2006
Language:EN
The application published by WIPO in one of the EPO official languages on 14.07.2005 takes the place of the publication of the European patent application.
[2006/36]
Type: B1 Patent specification 
No.:EP1697521
Date:02.06.2010
Language:EN
[2010/22]
Search report(s)International search report - published on:US13.04.2006
(Supplementary) European search report - dispatched on:EP29.12.2006
ClassificationIPC:C12N15/63, C12N15/85, C12N7/02, A61K35/76
[2007/04]
CPC:
C12N7/00 (EP,US); A61K39/12 (EP,US); A61P31/16 (EP);
C12N15/85 (EP,US); A61K2039/5254 (EP,US); A61K2039/543 (EP,US);
A61K39/145 (EP,US); C12N2760/16134 (EP,US); C12N2760/16151 (EP,US);
C12N2760/16152 (EP,US); C12N2760/16162 (EP,US); C12N2760/16234 (EP,US);
C12N2760/16251 (EP,US); C12N2760/16252 (EP,US); C12N2760/16261 (EP,US);
C12N2840/20 (EP,US) (-)
Former IPC [2006/36]C12N15/63
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2006/36]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
LVNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:MULTIPLASMID-SYSTEM ZUR ERZEUGUNG DES GRIPPEVIRUS[2006/36]
English:MULTI PLASMID SYSTEM FOR THE PRODUCTION OF INFLUENZA VIRUS[2006/36]
French:SYSTEME A PLASMIDES MULTIPLES POUR LA PRODUCTION DU VIRUS DE LA GRIPPE[2006/36]
Entry into regional phase28.06.2006National basic fee paid 
28.06.2006Search fee paid 
28.06.2006Designation fee(s) paid 
28.06.2006Examination fee paid 
Examination procedure28.06.2006Examination requested  [2006/36]
31.08.2006Amendment by applicant (claims and/or description)
14.05.2007Despatch of a communication from the examining division (Time limit: M06)
21.11.2007Reply to a communication from the examining division
13.12.2007Despatch of a communication from the examining division (Time limit: M04)
21.04.2008Reply to a communication from the examining division
13.05.2008Despatch of a communication from the examining division (Time limit: M04)
23.09.2008Reply to a communication from the examining division
23.07.2009Communication of intention to grant the patent
26.11.2009Fee for grant paid
26.11.2009Fee for publishing/printing paid
Opposition(s)03.03.2011No opposition filed within time limit [2011/19]
Fees paidRenewal fee
13.12.2006Renewal fee patent year 03
24.12.2007Renewal fee patent year 04
28.03.2008Renewal fee patent year 05
28.12.2009Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT02.06.2010
CY02.06.2010
CZ02.06.2010
DK02.06.2010
EE02.06.2010
FI02.06.2010
LT02.06.2010
PL02.06.2010
RO02.06.2010
SE02.06.2010
SI02.06.2010
SK02.06.2010
TR02.06.2010
BG02.09.2010
GR03.09.2010
IS02.10.2010
PT04.10.2010
IE22.12.2010
LU22.12.2010
MC31.12.2010
[2017/51]
Former [2013/42]AT02.06.2010
CY02.06.2010
CZ02.06.2010
DK02.06.2010
EE02.06.2010
FI02.06.2010
LT02.06.2010
PL02.06.2010
RO02.06.2010
SE02.06.2010
SI02.06.2010
SK02.06.2010
TR02.06.2010
BG02.09.2010
GR03.09.2010
IS02.10.2010
PT04.10.2010
IE22.12.2010
LU22.12.2010
MC31.12.2010
Former [2012/47]AT02.06.2010
BG02.06.2010
CY02.06.2010
CZ02.06.2010
DK02.06.2010
EE02.06.2010
FI02.06.2010
LT02.06.2010
PL02.06.2010
RO02.06.2010
SE02.06.2010
SI02.06.2010
SK02.06.2010
TR02.06.2010
GR03.09.2010
IS02.10.2010
PT04.10.2010
IE22.12.2010
LU22.12.2010
MC31.12.2010
Former [2012/44]AT02.06.2010
BG02.06.2010
CY02.06.2010
CZ02.06.2010
DK02.06.2010
EE02.06.2010
FI02.06.2010
LT02.06.2010
PL02.06.2010
RO02.06.2010
SE02.06.2010
SI02.06.2010
SK02.06.2010
GR03.09.2010
IS02.10.2010
PT04.10.2010
IE22.12.2010
LU22.12.2010
MC31.12.2010
Former [2012/41]AT02.06.2010
BG02.06.2010
CY02.06.2010
CZ02.06.2010
DK02.06.2010
EE02.06.2010
FI02.06.2010
LT02.06.2010
PL02.06.2010
RO02.06.2010
SE02.06.2010
SI02.06.2010
SK02.06.2010
GR03.09.2010
IS02.10.2010
PT04.10.2010
IE22.12.2010
MC31.12.2010
Former [2011/47]AT02.06.2010
CY02.06.2010
CZ02.06.2010
DK02.06.2010
EE02.06.2010
FI02.06.2010
LT02.06.2010
PL02.06.2010
RO02.06.2010
SE02.06.2010
SI02.06.2010
SK02.06.2010
GR03.09.2010
IS02.10.2010
PT04.10.2010
IE22.12.2010
MC31.12.2010
Former [2011/36]AT02.06.2010
CY02.06.2010
CZ02.06.2010
DK02.06.2010
EE02.06.2010
FI02.06.2010
LT02.06.2010
PL02.06.2010
RO02.06.2010
SE02.06.2010
SI02.06.2010
SK02.06.2010
GR03.09.2010
IS02.10.2010
PT04.10.2010
MC31.12.2010
Former [2011/19]AT02.06.2010
CY02.06.2010
CZ02.06.2010
DK02.06.2010
EE02.06.2010
FI02.06.2010
LT02.06.2010
PL02.06.2010
RO02.06.2010
SE02.06.2010
SI02.06.2010
SK02.06.2010
GR03.09.2010
IS02.10.2010
PT04.10.2010
Former [2011/13]AT02.06.2010
CY02.06.2010
CZ02.06.2010
EE02.06.2010
FI02.06.2010
LT02.06.2010
PL02.06.2010
RO02.06.2010
SE02.06.2010
SI02.06.2010
SK02.06.2010
GR03.09.2010
IS02.10.2010
PT04.10.2010
Former [2011/11]AT02.06.2010
CY02.06.2010
CZ02.06.2010
EE02.06.2010
FI02.06.2010
LT02.06.2010
PL02.06.2010
RO02.06.2010
SE02.06.2010
SI02.06.2010
SK02.06.2010
GR03.09.2010
PT04.10.2010
Former [2011/09]AT02.06.2010
CY02.06.2010
EE02.06.2010
FI02.06.2010
LT02.06.2010
PL02.06.2010
SE02.06.2010
SI02.06.2010
GR03.09.2010
Former [2011/05]AT02.06.2010
CY02.06.2010
FI02.06.2010
LT02.06.2010
PL02.06.2010
SE02.06.2010
SI02.06.2010
GR03.09.2010
Former [2011/04]AT02.06.2010
FI02.06.2010
LT02.06.2010
PL02.06.2010
SE02.06.2010
SI02.06.2010
GR03.09.2010
Former [2011/01]AT02.06.2010
FI02.06.2010
LT02.06.2010
SE02.06.2010
SI02.06.2010
GR03.09.2010
Former [2010/51]AT02.06.2010
FI02.06.2010
LT02.06.2010
SE02.06.2010
SI02.06.2010
Documents cited:Search[Y]WO03091401  (MEDIMMUNE VACCINES INC [US], et al) [Y] 1-20 * the whole document *;
 [Y]  - HOFFMANN E ET AL, "Eight-plasmid system for rapid generation of influenza virus vaccines", VACCINE, BUTTERWORTH SCIENTIFIC. GUILDFORD, GB, (20020819), vol. 20, no. 25-26, ISSN 0264-410X, pages 3165 - 3170, XP004374556 [Y] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.1016/S0264-410X(02)00268-2
 [Y]  - SCHICKLI J H ET AL, "Plasmid-only rescue of influenza A virus vaccine candidates", PHILOSOPHICAL TRANSACTIONS. ROYAL SOCIETY OF LONDON. BIOLOGICAL SCIENCES, ROYAL SOCIETY, LONDON, GB, (20011229), vol. 356, no. 1416, ISSN 0962-8436, pages 1965 - 1973, XP002314283 [Y] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.1098/rstb.2001.0979
 [Y]  - HOFFMANN E ET AL, "Rescue of influenza B virus from eight plasmids", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, (20020820), vol. 99, no. 17, ISSN 0027-8424, pages 11411 - 11416, XP002973258 [Y] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.1073/pnas.172393399
 [Y]  - SUBBARAO K ET AL, "Evaluation of a genetically modified reassortant H5N1 influenza A virus vaccine candidate generated by plasmid-based reverse genetics", VIROLOGY, RAVEN PRESS, NEW YORK, NY, US, (20030105), vol. 305, no. 1, ISSN 0042-6822, pages 192 - 200, XP002314284 [Y] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.1006/viro.2002.1742
 [Y]  - FODOR E ET AL, "Rescue of influenza A virus from recombinant DNA", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, (199911), vol. 73, no. 11, ISSN 0022-538X, pages 9679 - 9682, XP002151487 [Y] 1-20 * the whole document *
 [A]  - NEUMANN G ET AL, "Generation of influenza A virus from cloned cDNAs--historical perspective and outlook for the new millenium", REVIEWS IN MEDICAL VIROLOGY, CHICHESTER, GB, (200201), vol. 12, no. 1, ISSN 1052-9276, pages 13 - 30, XP002314285 [A] 1-20 * the whole document *

DOI:   http://dx.doi.org/10.1002/rmv.332
International search[Y]US6951754  (HOFFMANN ERICH [US]);
 [Y]  - HOFFMANN E. ET AL, "A DNA transfection system for generation of influenza A virus from eight plasmids", PNAS, (20000523), vol. 97, no. 11, pages 6108 - 6113, XP000982038

DOI:   http://dx.doi.org/10.1073/pnas.100133697
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.